Published in JAMA Psychiatry on August 01, 2013
Imaging Predictors of Treatment Response in Depression | NCT00367341
Resting-state connectivity biomarkers define neurophysiological subtypes of depression. Nat Med (2016) 2.12
Depression-Related Increases and Decreases in Appetite: Dissociable Patterns of Aberrant Activity in Reward and Interoceptive Neurocircuitry. Am J Psychiatry (2016) 1.43
Annual Research Review: Building a science of personalized intervention for youth mental health. J Child Psychol Psychiatry (2015) 1.43
The promise of cognitive behavior therapy for treatment of severe mental disorders: a review of recent developments. World Psychiatry (2014) 1.42
Resting-state networks link invasive and noninvasive brain stimulation across diverse psychiatric and neurological diseases. Proc Natl Acad Sci U S A (2014) 1.42
Interoceptive predictions in the brain. Nat Rev Neurosci (2015) 1.36
Prediction as a humanitarian and pragmatic contribution from human cognitive neuroscience. Neuron (2015) 1.33
Major depressive disorder is associated with abnormal interoceptive activity and functional connectivity in the insula. Biol Psychiatry (2013) 1.24
The Personalized Advantage Index: translating research on prediction into individualized treatment recommendations. A demonstration. PLoS One (2014) 1.22
Deep brain stimulation (DBS) at the interface of neurology and psychiatry. J Clin Invest (2013) 1.07
Pretreatment brain states identify likely nonresponse to standard treatments for depression. Biol Psychiatry (2013) 1.05
Identifying predictors, moderators, and mediators of antidepressant response in major depressive disorder: neuroimaging approaches. Am J Psychiatry (2015) 1.04
Computational psychiatry as a bridge from neuroscience to clinical applications. Nat Neurosci (2016) 1.04
Uncovering the role of the insula in non-motor symptoms of Parkinson's disease. Brain (2014) 1.03
Brain connectomics predict response to treatment in social anxiety disorder. Mol Psychiatry (2015) 0.95
Resting-state connectivity predictors of response to psychotherapy in major depressive disorder. Neuropsychopharmacology (2015) 0.94
Mechanisms of antidepressant resistance. Front Pharmacol (2013) 0.92
Neuroimaging-based biomarkers for treatment selection in major depressive disorder. Dialogues Clin Neurosci (2014) 0.91
Magnetic Resonance Imaging Measures of Brain Structure to Predict Antidepressant Treatment Outcome in Major Depressive Disorder. EBioMedicine (2014) 0.89
Clinical, cognitive, and functional connectivity correlations of resting-state intrinsic brain activity alterations in unmedicated depression. J Affect Disord (2014) 0.87
Cognitive Behavioral Therapy Lowers Elevated Functional Connectivity in Depressed Adolescents. EBioMedicine (2017) 0.86
Reconciling variable findings of white matter integrity in major depressive disorder. Neuropsychopharmacology (2013) 0.86
Test-retest reliability of pain-related brain activity in healthy controls undergoing experimental thermal pain. J Pain (2014) 0.86
A bihemispheric autonomic model for traumatic stress effects on health and behavior. Front Psychol (2014) 0.85
Rightward dominance in temporal high-frequency electrical asymmetry corresponds to higher resting heart rate and lower baroreflex sensitivity in a heterogeneous population. Brain Behav (2015) 0.84
Using biomarkers to predict treatment response in major depressive disorder: evidence from past and present studies. Dialogues Clin Neurosci (2014) 0.84
Magnetic resonance imaging predictors of treatment response in late-life depression. J Geriatr Psychiatry Neurol (2013) 0.84
Anterior insula volume and guilt: neurobehavioral markers of recurrence after early childhood major depressive disorder. JAMA Psychiatry (2015) 0.84
Moderation of the Relationship Between Reward Expectancy and Prediction Error-Related Ventral Striatal Reactivity by Anhedonia in Unmedicated Major Depressive Disorder: Findings From the EMBARC Study. Am J Psychiatry (2015) 0.84
Treatment decisions based on scalar and functional baseline covariates. Biometrics (2015) 0.84
Preliminary Findings Supporting Insula Metabolic Activity as a Predictor of Outcome to Psychotherapy and Medication Treatments for Depression. J Neuropsychiatry Clin Neurosci (2015) 0.83
The neuroscience of depression: implications for assessment and intervention. Behav Res Ther (2014) 0.83
Model specification and the reliability of fMRI results: implications for longitudinal neuroimaging studies in psychiatry. PLoS One (2014) 0.83
Diagnostic and therapeutic utility of neuroimaging in depression: an overview. Neuropsychiatr Dis Treat (2014) 0.82
Common and distinct patterns of grey-matter volume alteration in major depression and bipolar disorder: evidence from voxel-based meta-analysis. Mol Psychiatry (2016) 0.81
Future in psychopathology research. Schizophr Bull (2014) 0.81
Development and preliminary evaluation of a telephone-based mindfulness training intervention for survivors of critical illness. Ann Am Thorac Soc (2014) 0.80
Telephone and in-person cognitive behavioral therapy for major depression after traumatic brain injury: a randomized controlled trial. J Neurotrauma (2015) 0.80
Predicting clinical outcome using brain activation associated with set-shifting and central coherence skills in Anorexia Nervosa. J Psychiatr Res (2014) 0.80
Functional and structural alterations in the cingulate motor area relate to decreased fronto-striatal coupling in major depressive disorder with psychomotor disturbances. Front Psychiatry (2014) 0.80
Neuroimaging for psychotherapy research: current trends. Psychother Res (2014) 0.79
Altering the Cognitive-Affective Dysfunctions of Psychopathic and Externalizing Offender Subtypes with Cognitive Remediation. Clin Psychol Sci (2015) 0.79
Biomarker Development for Brain-Based Disorders: Recent Progress in Psychiatry. J Neurol Psychol (2013) 0.79
Taking Personalized Medicine Seriously: Biomarker Approaches in Phase IIb/III Studies in Major Depression and Schizophrenia. Innov Clin Neurosci (2015) 0.79
Functional Connectivity of the Subcallosal Cingulate Cortex And Differential Outcomes to Treatment With Cognitive-Behavioral Therapy or Antidepressant Medication for Major Depressive Disorder. Am J Psychiatry (2017) 0.78
Interventional psychiatry: how should psychiatric educators incorporate neuromodulation into training? Acad Psychiatry (2014) 0.78
Brain Activation During Emotional Memory Processing Associated with Subsequent Course of Depression. Neuropsychopharmacology (2015) 0.78
Salience Network Functional Connectivity Predicts Placebo Effects in Major Depression. Biol Psychiatry Cogn Neurosci Neuroimaging (2016) 0.78
Significance of right anterior insula activity for mental health intervention. JAMA Psychiatry (2014) 0.78
Recalling happy memories in remitted depression: a neuroimaging investigation of the repair of sad mood. Cogn Affect Behav Neurosci (2014) 0.77
Is depression simply a nonspecific response to brain injury? Curr Psychiatry Rep (2013) 0.77
Studying depression using imaging and machine learning methods. Neuroimage Clin (2015) 0.77
Research domain criteria: a final paradigm for psychiatry? Front Hum Neurosci (2015) 0.77
Mindfulness training increases cooperative decision making in economic exchanges: Evidence from fMRI. Neuroimage (2016) 0.76
Insula and striatum activity in effort-related monetary reward processing in gambling disorder: the role of depressive symptomatology. Neuroimage Clin (2014) 0.76
Multidimensional prediction of treatment response to antidepressants with cognitive control and functional MRI. Brain (2017) 0.76
An active inference theory of allostasis and interoception in depression. Philos Trans R Soc Lond B Biol Sci (2016) 0.76
Resting-state functional connectivity of the amygdala and longitudinal changes in depression severity in adolescent depression. J Affect Disord (2016) 0.76
Attenuation of Frontostriatal Connectivity During Reward Processing Predicts Response to Psychotherapy in Major Depressive Disorder. Neuropsychopharmacology (2016) 0.76
Role of functional imaging in the development and refinement of invasive neuromodulation for psychiatric disorders. World J Radiol (2014) 0.76
Early changes in emotional processing as a marker of clinical response to SSRI treatment in depression. Transl Psychiatry (2016) 0.76
A spectroscopic approach toward depression diagnosis: local metabolism meets functional connectivity. Eur Arch Psychiatry Clin Neurosci (2016) 0.76
Subclinical depression severity is associated with distinct patterns of functional connectivity for subregions of anterior cingulate cortex. J Psychiatr Res (2015) 0.76
Internet-Based Cognitive-Behavioral Therapy for Depression: Current Progress and Future Directions. Harv Rev Psychiatry (2017) 0.76
Early cortical biomarkers of longitudinal transcutaneous vagus nerve stimulation treatment success in depression. Neuroimage Clin (2016) 0.75
Neural Correlates of Antidepressant Treatment Response in Adolescents with Major Depressive Disorder. J Child Adolesc Psychopharmacol (2016) 0.75
Depression: a change of mind. Nature (2014) 0.75
[PET reveals the best antidepressant therapy]. MMW Fortschr Med (2013) 0.75
On the Origin of Interoception. Front Psychol (2016) 0.75
How to Perform and Interpret Functional Magnetic Resonance Imaging Studies in Functional Gastrointestinal Disorders. J Neurogastroenterol Motil (2017) 0.75
Treating major depression with yoga: A prospective, randomized, controlled pilot trial. PLoS One (2017) 0.75
Lateralization for speech predicts therapeutic response to cognitive behavioral therapy for depression. Psychiatry Res (2015) 0.75
Brain Functional Effects of Psychopharmacological Treatment in Major Depression: a Focus on Neural Circuitry of Affective Processing. Curr Neuropharmacol (2015) 0.75
Psychotherapy and Neuroimaging. Focus (Am Psychiatr Publ) (2014) 0.75
Insula and amygdala resting-state functional connectivity differentiate bipolar from unipolar depression. Acta Psychiatr Scand (2017) 0.75
Interventional psychiatry: why now? J Clin Psychiatry (2014) 0.75
Neural Implications of Psychotherapy, Pharmacotherapy, and Combined Treatment in Major Depressive Disorder. Mens Sana Monogr (2016) 0.75
Role of Hybrid Brain Imaging in Neuropsychiatric Disorders. Diagnostics (Basel) (2015) 0.75
Certainly not the first neuroimaging treatment selection biomarker. JAMA Psychiatry (2014) 0.75
The Holy Grail of Psychiatry. Cerebrum (2015) 0.75
Gamma-Hydroxybutyrate Increases Resting State Limbic Perfusion and Body and Emotion Awareness in Humans. Neuropsychopharmacology (2017) 0.75
Erratum: Resting-state connectivity biomarkers define neurophysiological subtypes of depression. Nat Med (2017) 0.75
Altered right anterior insular connectivity and loss of associated functions in adolescent chronic fatigue syndrome. PLoS One (2017) 0.75
Fractional amplitude of low-frequency fluctuations (fALFF) in post-stroke depression. Neuroimage Clin (2017) 0.75
The Structure of Personality Disorders within a Depressed Sample: Implications for Personalizing Treatment. Pers Med Psychiatr (2017) 0.75
Neuroticism and Individual Differences in Neural Function in Unmedicated Major Depression: Findings from the EMBARC Study. Biol Psychiatry Cogn Neurosci Neuroimaging (2016) 0.75
A rating scale for depression. J Neurol Neurosurg Psychiatry (1960) 90.89
The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA (2003) 34.83
A fast diffeomorphic image registration algorithm. Neuroimage (2007) 21.56
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med (2000) 18.04
How do you feel--now? The anterior insula and human awareness. Nat Rev Neurosci (2009) 17.22
Deep brain stimulation for treatment-resistant depression. Neuron (2005) 12.39
Neural systems supporting interoceptive awareness. Nat Neurosci (2004) 11.88
Neural mechanisms of autonomic, affective, and cognitive integration. J Comp Neurol (2005) 5.86
Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol (1979) 5.83
Circuitry and functional aspects of the insular lobe in primates including humans. Brain Res Brain Res Rev (1996) 5.78
Cingulate function in depression: a potential predictor of treatment response. Neuroreport (1997) 4.48
Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it? Mol Psychiatry (2012) 4.40
Psychosocial disability during the long-term course of unipolar major depressive disorder. Arch Gen Psychiatry (2000) 3.73
Attending to the present: mindfulness meditation reveals distinct neural modes of self-reference. Soc Cogn Affect Neurosci (2007) 3.66
Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers. Am J Psychiatry (2006) 3.47
Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. Am J Psychiatry (2011) 3.34
Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy. Arch Gen Psychiatry (2004) 3.33
Residual symptoms after partial remission: an important outcome in depression. Psychol Med (1995) 3.23
Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. Am J Psychiatry (2001) 3.18
The current state of cognitive therapy: a 40-year retrospective. Arch Gen Psychiatry (2005) 3.07
Frontocingulate dysfunction in depression: toward biomarkers of treatment response. Neuropsychopharmacology (2010) 2.97
Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report. Am J Psychiatry (2007) 2.84
Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav Immun (2007) 2.75
Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings. Arch Gen Psychiatry (2001) 2.67
Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex. Am J Psychiatry (1999) 2.32
Anterior cingulate activity as a predictor of degree of treatment response in major depression: evidence from brain electrical tomography analysis. Am J Psychiatry (2001) 2.31
Regional cerebral glucose utilization in patients with a range of severities of unipolar depression. Biol Psychiatry (2002) 2.26
Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. Am J Psychiatry (2007) 2.15
A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression. Arch Gen Psychiatry (2009) 2.15
Cardiology Patient Page. C-reactive protein: a simple test to help predict risk of heart attack and stroke. Circulation (2003) 1.98
Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness? Am J Psychiatry (2000) 1.89
Glucose metabolism in the amygdala in depression: relationship to diagnostic subtype and plasma cortisol levels. Pharmacol Biochem Behav (2002) 1.80
What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression. Psychiatr Serv (2009) 1.77
Employer burden of mild, moderate, and severe major depressive disorder: mental health services utilization and costs, and work performance. Depress Anxiety (2010) 1.72
The use of referenced-EEG (rEEG) in assisting medication selection for the treatment of depression. J Psychiatr Res (2010) 1.61
Stuck in a rut: rethinking depression and its treatment. Trends Neurosci (2010) 1.60
Predictive neural biomarkers of clinical response in depression: a meta-analysis of functional and structural neuroimaging studies of pharmacological and psychological therapies. Neurobiol Dis (2012) 1.52
Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine. Psychiatry Res (1999) 1.51
STAR*D: revising conventional wisdom. CNS Drugs (2009) 1.41
Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression. Am J Psychiatry (2003) 1.40
Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD study. Psychiatry Res (2009) 1.40
Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for treatment of major depression. J Neurosurg (2003) 1.39
Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. Introduction. J Affect Disord (2009) 1.34
Timing of onset of antidepressant response with fluoxetine treatment. Am J Psychiatry (2000) 1.30
Toward clinically useful neuroimaging in depression treatment: prognostic utility of subgenual cingulate activity for determining depression outcome in cognitive therapy across studies, scanners, and patient characteristics. Arch Gen Psychiatry (2012) 1.27
Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo. Br J Psychiatry Suppl (1993) 1.26
Moderation of antidepressant response by the serotonin transporter gene. Br J Psychiatry (2009) 1.25
Attentional modulation of primary interoceptive and exteroceptive cortices. Cereb Cortex (2012) 1.23
Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder. J Psychiatry Neurosci (2009) 1.16
Cerebral blood flow changes during vagus nerve stimulation for depression. Psychiatry Res (2006) 1.13
Depression beliefs, treatment preference, and outcomes in a randomized trial for major depressive disorder. J Psychiatr Res (2011) 1.12
The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Commentary and review. Arch Gen Psychiatry (1985) 1.11
Bupropion and venlafaxine responders differ in pretreatment regional cerebral metabolism in unipolar depression. Biol Psychiatry (2005) 1.09
Predictors of remission in depression to individual and combined treatments (PReDICT): study protocol for a randomized controlled trial. Trials (2012) 1.06
The Canadian Biomarker Integration Network in Depression (CAN-BIND): advances in response prediction. Curr Pharm Des (2012) 1.05
Volumetric MRI study of the insular cortex in individuals with current and past major depression. J Affect Disord (2009) 1.05
Antidepressant treatment and altered CYP2D6 activity: are pharmacokinetic variations clinically relevant? J Psychiatr Pract (2011) 0.98
Treating depression after initial treatment failure: directly comparing switch and augmenting strategies in STAR*D. J Clin Psychopharmacol (2012) 0.98
Pretreatment regional brain glucose uptake in the midbrain on PET may predict remission from a major depressive episode after three months of treatment. Psychiatry Res (2009) 0.94
Symptomatic and functional improvement in employed depressed patients: a double-blind clinical trial of desvenlafaxine versus placebo. J Clin Psychopharmacol (2011) 0.94
Baseline cerebral hypermetabolism associated with carbamazepine response, and hypometabolism with nimodipine response in mood disorders. Biol Psychiatry (1999) 0.93
Pretreatment cerebral metabolic activity correlates with antidepressant efficacy of vagus nerve stimulation in treatment-resistant major depression: a potential marker for response? J Affect Disord (2012) 0.93
Inflammatory biomarkers and depression. Neurotox Res (2010) 0.92
Critical comments for roles of biomarkers in the diagnosis and treatment of cancer. Cancer Treat Rev (2011) 0.85
Modern management of acute myocardial infarction. Curr Probl Cardiol (2012) 0.81
Stability of resting deoxyglucose metabolic values in PET studies of schizophrenia. Psychiatry Res (1991) 0.81
Toward discovery science of human brain function. Proc Natl Acad Sci U S A (2010) 15.22
Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat Neurosci (2012) 4.71
Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosom Med (2007) 4.49
Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nat Neurosci (2007) 4.46
A comprehensive assessment of regional variation in the impact of head micromovements on functional connectomics. Neuroimage (2013) 3.96
A whole brain fMRI atlas generated via spatially constrained spectral clustering. Hum Brain Mapp (2011) 3.75
Neurobiological mechanisms of the placebo effect. J Neurosci (2005) 3.41
A multicenter pilot study of subcallosal cingulate area deep brain stimulation for treatment-resistant depression. J Neurosurg (2011) 3.30
Family-focused treatment for adolescents with bipolar disorder: results of a 2-year randomized trial. Arch Gen Psychiatry (2008) 3.26
Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry (2010) 3.14
Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biol Psychiatry (2008) 3.00
Posttraumatic stress disorder: a state-of-the-science review. J Psychiatr Res (2005) 2.61
Deep brain stimulation for treatment-resistant depression: follow-up after 3 to 6 years. Am J Psychiatry (2011) 2.46
Harnessing neuroplasticity for clinical applications. Brain (2011) 2.45
Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety. J Clin Psychiatry (2010) 2.39
Disease state prediction from resting state functional connectivity. Magn Reson Med (2009) 2.37
Misuse of the FDA's humanitarian device exemption in deep brain stimulation for obsessive-compulsive disorder. Health Aff (Millwood) (2011) 2.34
VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms. Neuropsychopharmacology (2006) 2.24
Unmasking disease-specific cerebral blood flow abnormalities: mood challenge in patients with remitted unipolar depression. Am J Psychiatry (2002) 2.23
Neurobiological and psychiatric consequences of child abuse and neglect. Dev Psychobiol (2010) 2.17
Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. Am J Psychiatry (2007) 2.15
A tractography analysis of two deep brain stimulation white matter targets for depression. Biol Psychiatry (2008) 1.90
Functional neuroanatomical substrates of altered reward processing in major depressive disorder revealed by a dopaminergic probe. Arch Gen Psychiatry (2005) 1.85
Risk and resilience markers in bipolar disorder: brain responses to emotional challenge in bipolar patients and their healthy siblings. Am J Psychiatry (2006) 1.84
Racial disparity in knee arthroplasty utilization in the veterans health administration. Arthritis Rheum (2005) 1.84
Subcallosal cingulate deep brain stimulation for treatment-resistant unipolar and bipolar depression. Arch Gen Psychiatry (2012) 1.83
Corticolimbic brain reactivity to social signals of threat before and after sertraline treatment in generalized social phobia. Biol Psychiatry (2012) 1.78
Characterizing variation in the functional connectome: promise and pitfalls. Trends Cogn Sci (2012) 1.77
Understanding of the benefits of coronary revascularization procedures among patients who are offered such procedures. Am Heart J (2007) 1.69
Standardizing the intrinsic brain: towards robust measurement of inter-individual variation in 1000 functional connectomes. Neuroimage (2013) 1.60
Stuck in a rut: rethinking depression and its treatment. Trends Neurosci (2010) 1.60
Racial/ethnic variations in physician recommendations for cardiac revascularization. Am J Public Health (2003) 1.59
Prevention of depression among Icelandic adolescents. Behav Res Ther (2009) 1.57
Impact of public housing relocations: are changes in neighborhood conditions related to STIs among relocaters? Sex Transm Dis (2014) 1.54
Association of pre-onset cannabis, alcohol, and tobacco use with age at onset of prodrome and age at onset of psychosis in first-episode patients. Am J Psychiatry (2009) 1.49
Neural stimulation successfully treats depression in patients with prior ablative cingulotomy. Am J Psychiatry (2008) 1.49
Receptor architecture of human cingulate cortex: evaluation of the four-region neurobiological model. Hum Brain Mapp (2009) 1.48
Clinical applications of the functional connectome. Neuroimage (2013) 1.48
Neurophysiological investigation of spontaneous correlated and anticorrelated fluctuations of the BOLD signal. J Neurosci (2013) 1.47
Deep brain stimulation for psychiatric disorders. Annu Rev Neurosci (2011) 1.47
Resting state and task-induced deactivation: A methodological comparison in patients with schizophrenia and healthy controls. Hum Brain Mapp (2010) 1.46
A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression. Biol Psychiatry (2005) 1.43
Public health consequences of state immigration laws. South Med J (2011) 1.41
Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for treatment of major depression. J Neurosurg (2003) 1.39
Defining the neural circuitry of depression: toward a new nosology with therapeutic implications. Biol Psychiatry (2007) 1.39
Scientific and ethical issues related to deep brain stimulation for disorders of mood, behavior, and thought. Arch Gen Psychiatry (2009) 1.33
An fMRI study investigating cognitive modulation of brain regions associated with emotional processing of visual stimuli. Neuropsychologia (2003) 1.29
State and trait influences on mood regulation in bipolar disorder: blood flow differences with an acute mood challenge. Biol Psychiatry (2003) 1.28
Family-focused treatment for adolescents with bipolar disorder. J Affect Disord (2004) 1.24
Cortisol, dehydroepiandrosterone, and estradiol measured over 24 hours in women with childhood sexual abuse-related posttraumatic stress disorder. J Nerv Ment Dis (2007) 1.24
Learning and comparing functional connectomes across subjects. Neuroimage (2013) 1.23
Hormone use and patient concerns after the findings of the Women's Health Initiative. Menopause (2005) 1.17
Decreased alcohol consumption in outpatient drinkers is associated with improved quality of life and fewer alcohol-related consequences. J Gen Intern Med (2002) 1.17
Group motivational interviewing to promote adherence to antiretroviral medications and risk reduction behaviors in HIV infected women. AIDS Behav (2011) 1.17
Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder. J Psychiatry Neurosci (2009) 1.16
Transcranial magnetic stimulation reduces pain in patients with major depression: a sham-controlled study. J Nerv Ment Dis (2007) 1.15
Treatment resistant depression as a failure of brain homeostatic mechanisms: implications for deep brain stimulation. Exp Neurol (2009) 1.12
Depression beliefs, treatment preference, and outcomes in a randomized trial for major depressive disorder. J Psychiatr Res (2011) 1.12
Decreased cortical representation of genital somatosensory field after childhood sexual abuse. Am J Psychiatry (2013) 1.10
Exercise and pharmacotherapy in patients with major depression: one-year follow-up of the SMILE study. Psychosom Med (2010) 1.09
Cognitive-behavioral intervention for depressed, substance-abusing adolescents: development and pilot testing. J Am Acad Child Adolesc Psychiatry (2003) 1.07
Predictors of remission in depression to individual and combined treatments (PReDICT): study protocol for a randomized controlled trial. Trials (2012) 1.06
Identifying illness parameters in fatiguing syndromes using classical projection methods. Pharmacogenomics (2006) 1.05
Gene expression correlates of unexplained fatigue. Pharmacogenomics (2006) 1.03
Variation in brain-derived neurotrophic factor (BDNF) gene is associated with symptoms of depression. J Affect Disord (2008) 1.02
Validity of the 30-item geriatric depression scale in patients with Parkinson's disease. Mov Disord (2006) 0.99
Tractography-activation models applied to subcallosal cingulate deep brain stimulation. Brain Stimul (2013) 0.99
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases. Biol Psychiatry (2007) 0.99
Accelerated repetitive transcranial magnetic stimulation for treatment-resistant depression. Depress Anxiety (2010) 0.97
Neuropsychological impact of Cg25 deep brain stimulation for treatment-resistant depression: preliminary results over 12 months. J Nerv Ment Dis (2008) 0.96
The aftermath of public housing relocation: relationship to substance misuse. Drug Alcohol Depend (2013) 0.96
Exploratory structural equation modeling of resting-state fMRI: applicability of group models to individual subjects. Neuroimage (2009) 0.96
Neuropsychologic effects of neuromodulation techniques for treatment-resistant depression: a review. Brain Stimul (2010) 0.96
Modeling conflict and error in the medial frontal cortex. Hum Brain Mapp (2011) 0.95
Beyond Depression: Towards a Process-Based Approach to Research, Diagnosis, and Treatment. Clin Psychol (New York) (2011) 0.95
Tai chi and perceived health status in older adults who are transitionally frail: a randomized controlled trial. Phys Ther (2007) 0.94
Personality influences limbic-cortical interactions during sad mood induction. Neuroimage (2003) 0.94
Changes in Exposure to Neighborhood Characteristics are Associated with Sexual Network Characteristics in a Cohort of Adults Relocating from Public Housing. AIDS Behav (2015) 0.93
Factors associated with functional recovery in bipolar disorder patients. Bipolar Disord (2010) 0.92
Deep brain stimulation for treatment-resistant depression. Am J Psychiatry (2010) 0.92
Assessment and quantification of head motion in neuropsychiatric functional imaging research as applied to schizophrenia. J Int Neuropsychol Soc (2007) 0.92
Neuronal modulation of auditory attention by informative and uninformative spatial cues. Hum Brain Mapp (2009) 0.92
Prevention of depression among Icelandic adolescents: a 12-month follow-up. Behav Res Ther (2011) 0.92
Patient preferences for depression treatment programs and willingness to pay for treatment. J Ment Health Policy Econ (2007) 0.91
Effectiveness of quetiapine in rapid cycling bipolar disorder: a preliminary study. J Affect Disord (2007) 0.90